Zydus Cadila gets USFDA nod for blood pressure drug

Zydus Cadila gets USFDA nod for BP drug

Zydus Cadila said it has received USFDA approval to market Triamterene and Hydrochlorothiazide tablets, indicated to treat high blood pressure. The approval has been granted for the tablets in strengths of 37.5 mg/25 mg and 75 mg/50 mg. “The combination drug is used for the treatment of high blood pressure,” Zydus said. The drug will be made at the group’s facility at SEZ, Ahmedabad.PTI

Source: Read Full Article